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Caspofungin Induced Cell Wall
Changes of Candida Species
Influences Macrophage Interactions
Louise A. Walker* and Carol A. Munro
School of Medicine, Medical Sciences and Nutrition, Institute of Medical Sciences, University of Aberdeen, Aberdeen,
United Kingdom
Candida species are known to differ in their ability to cause infection and have
been shown to display varied susceptibilities to antifungal drugs. Treatment with the
echinocandin, caspofungin, leads to compensatory alterations in the fungal cell wall.
This study was performed to compare the structure and composition of the cell walls
of different Candida species alone and in response to caspofungin treatment, and to
evaluate how changes at the fungal cell surface affects interactions with macrophages.
We demonstrated that the length of the outer fibrillar layer varied between Candida
species and that, in most cases, reduced fibril length correlated with increased exposure
of β-1,3-glucan on the cell surface. Candida glabrata and Candida guilliermondii, which
had naturally more β-1,3-glucan exposed on the cell surface, were phagocytosed
significantly more efficiently by J774 macrophages. Treatment with caspofungin resulted
in increased exposure of chitin and β-1,3-glucan on the surface of the majority of
Candida species isolates that were tested, with the exception of C. glabrata and Candida
parapsilosis isolates. This increase in exposure of the inner cell wall polysaccharides, in
most cases, correlated with reduced uptake by macrophages and in turn, a decrease
in production of TNFα. Here we show that differences in the exposure of cell wall
carbohydrates and variations in the repertoire of covalently attached surface proteins
of different Candida species contributes to their recognition by immune cells.
Keywords: chitin, β-1,3-glucan, GPI-anchored proteins, fungal cell wall, echinocandin, macrophages, immune
response
INTRODUCTION
Candida species differ in their ability to cause infection. Candida albicans is the most common
cause of Candida bloodstream infections (40%), followed by Candida glabrata (29%), Candida
parapsilosis (11%), Candida tropicalis (4%), Candida dubliniensis (2%), and Candida lusitaniae
(<1%) (Data captured from England; Health Protection Report, 2018). Candida species also
have varied susceptibilities to antifungal drugs. The echinocandins act by specifically inhibiting
the synthesis of β-1,3-glucan in the fungal cell wall. The inhibition of β-1,3-glucan synthesis
occurs predominantly through inhibition of the catalytic Fks glucan synthase subunits (Kurtz and
Douglas, 1997). Caspofungin is one of the most widely used of the echinocandins in the clinic and
has fungicidal activity against the majority of Candida species. C. lusitaniae, C. parapsilosis, and
Candida guilliermondii are known to have relatively reduced susceptibility compared to C. albicans
and in recent years the incidence of clinical isolates of C. glabrata, which have acquired resistance
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to the echinocandins has increased (Garcia-Effron et al.,
2010; Pfaller et al., 2013). Alarmingly echinocandin-resistant
C. glabrata isolates (up to 38%) were also cross-resistant to
fluconazole (Pfaller et al., 2012, 2013). Acquired resistance is
predominantly mediated by point mutations within hotspot
regions in the FKS genes (Park et al., 2005; Balashov et al., 2006;
Garcia-Effron et al., 2010; Alexander et al., 2013; Pham et al.,
2014; Marti-Carrizosa et al., 2015).
The fungal cell wall determines cell shape, maintains cell wall
integrity and is recognized by the innate immune system. The
cell walls of Candida spp. in general are composed of an inner
core of chitin and β-1,3-glucan, which is covered by an outer
layer of cell wall proteins, the majority of which are covalently
linked to β-1,6-glucan by modified glycosylphosphatidylinositol
(GPI) anchors (Gow et al., 2017). The cell wall is a dynamic
structure which alters its composition in response to cell wall
stress by upregulating genes involved in cell wall synthesis, in
an attempt to restore the robustness of the cell wall (Walker
et al., 2008). Treatment of C. albicans with caspofungin has been
shown to lead to a compensatory increase in chitin content, in
vitro and in vivo (Walker et al., 2008; Lee et al., 2012). This
compensatory increase in chitin is not specific to C. albicans
as C. tropicalis, C. parapsilosis, C. guilliermondii, and isolates
of C. krusei also demonstrated an elevation in chitin content
in response to caspofungin treatment (Walker et al., 2013). In
addition, isolates of C. albicans, C. krusei, C. parapsilosis, and
C. guilliermondii, which have increased chitin content are less
susceptible to caspofungin (Walker et al., 2008, 2013). C. albicans
cells with elevated chitin contents have also been shown to be
less susceptible to caspofungin in a murine model of systemic
infection (Lee et al., 2012).
Putative GPI-modified cell wall proteins have been implicated
in susceptibility to caspofungin as deletion of specific proteins
leads to alterations in cell wall composition and subsequently to
differences in susceptibility to caspofungin (Plaine et al., 2008).
As a result of the cell wall remodeling that occurs in response
to caspofungin treatment, chitin and β-1,3-glucan also become
more exposed on the cell surface (Wheeler and Fink, 2006;
Wheeler et al., 2008; Mora-Montes et al., 2011).
The fungal cell wall plays an important role in immune
recognition as it is the first point of contact between the host and
pathogen. The main innate immune cells that are involved in the
recognition of invading pathogens are neutrophils, monocytes
andmacrophages (Netea et al., 2008). Components of the cell wall
act as pathogen associated molecular patterns (PAMPs), which
are recognized by pattern recognition receptors (PRRs) on host
cells (Brown and Gordon, 2001; Porcaro et al., 2003; Kohatsu
et al., 2006; McGreal et al., 2006; Netea et al., 2006, 2008). The
two main classes of PRRs are the Toll-like receptors (TLRs)
and the C-type lectin receptors (CLRs). The TLRs recognize
phospholipomannan and O-linked mannan, whereas the C-
type lectin receptors recognize β-1,3-glucan and mannan (Stahl
et al., 1978; Wileman et al., 1986; Jouault et al., 2003; McGreal
et al., 2006; Netea et al., 2006, 2008; Sato et al., 2006; Gow
et al., 2007; Taylor et al., 2007). The increased exposure of
chitin and β-1,3-glucan on the cell surface of C. albicans, in
response to caspofungin treatment, results in altered cytokine
production by immune cells, indicating that remodeling of
the cell wall influences interactions with host cells (Wheeler
and Fink, 2006; Wheeler et al., 2008; Mora-Montes et al.,
2011; Baltch et al., 2012a,b; Fidan et al., 2014). Caspofungin
treatment of C. albicans cells, followed by UV inactivation led
to increased recognition of fungal cells by the C-type lectin,
Dectin-1, which in turn increased cytokine production (Wheeler
and Fink, 2006; Wheeler et al., 2008). In contrast, increased
exposure of chitin on the surface of C. albicans has been shown
to result in reduced cytokine production (Mora-Montes et al.,
2011). Naturally occurring variations in the cell walls of different
C. albicans isolates influences the dependency on dectin-1 for
recognition and clearance of fungal cells (Marakalala et al., 2013).
In addition the role of dectin-1 in recognition of four different
Candida species, with differences in their cell wall carbohydrate
composition, also varies (Thompson et al., 2019).
Because different Candida species vary in their ability to
cause infection and vary in their cell wall composition, we
aimed to perform a detailed comparison of the cell wall
architectures of seven most prevalent Candida spp. and examine
how their surface carbohydrates and proteomes change in
response to caspofungin (CSF) treatment. In addition, the effect
of caspofungin-induced cell wall changes of the differentCandida
species on the response of host immune cells was investigated.
MATERIALS AND METHODS
Strains, Media, and Growth Conditions
The strains of each Candida species that were used in this study
had been typed and their genomes sequenced, these strains are
listed in Table 1. Strains were maintained on solid YPD medium
[1% (w/v) yeast extract, 2% (w/v) mycological peptone, 2% (w/v)
glucose, 2% (w/v) agar]. RPMI-1640 medium (Gibco, Paisley,
UK) was used for drug susceptibility testing and for growing
cultures for HPLC and proteomic analysis.
TABLE 1 | Caspofungin susceptibilities of sequenced strains of different Candida
speciesa.
Species Strain name Caspofungin
IC50 (µg/ml)
References
Candida albicans SC5314 0.032 (Gillum et al., 1984)
Candida dubliniensis CD36 0.064 (Sullivan et al., 1995)
Candida glabrata ATCC2001 0.064 American Type
Culture Collection
Candida tropicalis MYA-3404 0.125 American Type
Culture Collection
Candida lusitaniae ATCC42720 0.5 American Type
Culture Collection
Candida parapsilosis ATCC22019 1 American Type
Culture Collection
Candida guilliermondii ATCC6260 8 American Type
Culture Collection
aAs determined by broth microdilution testing. The IC50 was defined as the concentration
of caspofungin that inhibited 50% growth of each Candida species when cultured in
RPMI-1640 for 24 h at 37◦C.
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Preparation of FITC-Stained Candida spp
Staining of Candida spp. yeast cells with fluorescein
isothiocyanate (FITC) was performed as previously described
(Graham et al., 2006). Briefly, Candida spp. were grown in
YPD in the presence or absence of an IC50 concentration of
caspofungin (Walker et al., 2013) in YPD at 30◦C for 6 h.Candida
spp. cells were washed twice with PBS and stained for 10min
at room temperature in the dark with 1 mg/ml fluorescein
isothiocyanate (FITC) (Sigma, Dorset, United Kingdom) in
0.05M carbonate-bicarbonate buffer (pH 9.6) (BDH Chemicals,
VWR International, Leicestershire, United Kingdom). Cells were
then washed three times in 1x PBS to remove residual FITC and
were resuspended in 1x PBS. FITC-stained 6x105 Candida spp.
cells that had been pre-grown with or without IC50 caspofungin
were then added to the macrophages at a multiplicity of infection
(MOI) of 3 Candida spp. cells per macrophage, and incubated at
37◦C for 4 h before visualization.
Phagocytosis and Cytokine Assays
Macrophage Cell Culture
J774.1 murine macrophages (European Collection of Cell
Culture) were cultured in Dulbecco’s modified Eagle’s medium
(DMEM; Lonza Group, Ltd., Braine-l’Alleud, Belgium),
supplemented with 10% (vol/vol) fetal calf serum, 2% (wt/vol)
penicillin and streptomycin antibiotics (Invitrogen, Ltd.,
Paisley, United Kingdom) in tissue culture flasks (Nalge
Nunc, International, Hereford, United Kingdom) at 37◦C
and 5% (vol/vol) CO2. For phagocytosis assays, 2 × 10
5 J774.1
macrophages in 2ml supplemented DMEMmediumwere seeded
onto glass-based imaging dishes [Imaging dish CG 1.0; MACS
Miltenyi Biotec (130-098-282), Surrey, UK] and incubated at
37◦C with 5% CO2 for at least 2 h to allow for macrophage
adherence to the dish. Immediately prior to experiments, DMEM
medium was replaced with 2ml pre-warmed supplemented
CO2-independent medium (Gibco, Invitrogen, Paisley, UK) and
cultures used immediately for phagocytosis assays.
After 4 h of co-incubation 50 µl of supernatant was removed
from phagocytosis assays to allow determination of TNFα
production from J774 macrophages as a result of incubation with
each Candida species. TNFα concentrations were determined
using enzyme-linked immunosorbent assays (R&D Systems)
according to the manufacturer’s instructions.
Cell Wall Staining of Exposed Chitin and
Glucan
Candida spp. yeast cells were grown in YPD in the presence
or absence of an IC50 concentration of caspofungin in YPD at
30◦C for 6 h. Cells were stained with 5µg/ml Fc:Dectin1 protein
to visualize exposed β-1,3-glucan, as previously described (52).
Briefly, 1× 106 cells/sample were blocked with FACS block (0.5%
BSA, 5% HI-rabbit serum, 5mM ETDA, 2mM NaAzide in PBS)
for 30min. Cell pellets were harvested and washed 3× with 1ml
FACS wash (0.5% BSA, 5mM EDTA, 2mM NaAzide in PBS) at
4◦C. After washing, the cell pellet was resuspended in 100 µl of
5µg/ml Fc:Dectin1 protein (diluted from stock in FACS block)
and incubated for 1 h on ice. Cells were then washed 3 times
with 1ml FACS wash and resuspended in 200 µl FACS block
plus 1/200 anti-human Fc+Alexa-488 and incubated for 45min
on ice. After incubation cells were washed three times with 1ml
FACS wash and fixed with 200 µl 1% formaldehyde. After fixing
cells were also stained with 25µg/ml Wheat Germ Agglutinin
conjugated to Texas Red (WGA-TR). All samples were examined
by DIC and fluorescence microscopy using a Zeiss Axioplan 2
microscope. Images were recorded digitally using the Openlab
system (Openlab v 4.04, Improvision, Coventry, UK) and a
Hamamatsu C4742- 95 digital camera (Hamamatsu Photonics,
Hamamatsu, Hertfordshire, UK). In all experiments the exposure
time for a series of fluorescence images was fixed so the intensity
of fluorescence relative to a control was used as standard. Chitin
and β-1,3-glucan exposure were measured by quantifying WGA-
TR and Fc:Dectin1-488 fluorescence, respectively, of individual
yeast cells (Walker et al., 2008). Mean fluorescence intensities
were calculated for 50 individual cells of each Candida species,
for each condition.
High-Pressure Freezing (HPF)-
Transmission Electron Microscopy
(TEM)
Candida spp. yeast cells were grown in YPD at 30◦C for 6 h
and HPF was carried out as described previously (Walker et al.,
2010) with the following modifications. Briefly, samples were
prepared by high-pressure freezing with an EMPACT2 high-
pressure freezer and rapid transport system (Leica Microsystems
Ltd., Milton Keynes, United Kingdom). After freezing, cells were
freeze-substituted in substitution reagent (1% [wt/vol] OsO4 in
acetone) with a Leica EMAFS2. Samples were then embedded
in Epoxy resin and additional infiltration was provided under
a vacuum at 60◦C before embedding in Leica FSP specimen
containers and polymerizing at 60◦C for 48 h. Semithin survey
sections, 0.5µm thick, were stained with 1% toluidine blue
to identify areas containing cells. Ultrathin sections (60 nm)
were prepared with a Diatome diamond knife on a Leica UC6
ultramicrotome and stained with uranyl acetate and lead citrate
for examination with a Philips CM10 transmission microscope
(FEI UK Ltd., Cambridge, United Kingdom) and imaging
with a Gatan Bioscan 792 (Gatan United Kingdom, Abingdon,
United Kingdom). Image J was used to measure the thickness
of the inner (chitin and glucan) and outer cell wall by averaging
measurements for 30 cells, for each condition.
Antifungal Susceptibility Testing
CSF (Merck Research Laboratories, New Jersey, USA)
minimum inhibitory concentrations were determined by
broth micro-dilution testing using the CLSI guidelines M27-A3.
Drug concentrations ranged from 0.016 to 16µg/ml CSF.
Exponentially grown cultures were diluted to 2 × 106 cells/ml
in 2x RPMI-1640 and 100 µl of culture was added to each well.
Plates were incubated for 24 h at 37◦C. After incubation, optical
densities were read in a VERSAmax tunable microplate reader
(Molecular Devices, California, USA) at 405 nm.
HPLC Analysis of Cell Wall Composition
Cell walls were extracted as described previously (Mora-Montes
et al., 2011). Briefly, each Candida species was grown in
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RPMI-1640 for 3 h at 37◦C with shaking at 200 rpm. Each
Candida species was then subsequently treated with a sub-
MIC concentration of CSF (as determined from Table 1) for an
additional 2 h, or grown without addition of drug for a further
2 h, as an untreated control. Cells were collected by centrifugation
at 4,000 g for 5min, washed once with chilled deionized water,
resuspended in deionized water, and physically fractured with
glass beads in a FastPrep machine (Qbiogene). The lysed cells
were collected by centrifugation at 4,000 g for 5min. The pellet
containing the cell debris and walls was washed five times with
1M NaCl, resuspended in extraction buffer (500mM Tris-HCl
buffer, pH 7.5, 2% [wt/vol] SDS, 0.3M β-mercaptoethanol, and
1mM EDTA), boiled at 100◦C for 10min, and freeze-dried.
To quantify glucan, mannan, and chitin the cell walls were
acid hydrolyzed as previously described (Lee et al., 2012). The
hydrolyzed samples were analyzed by high-performance anion
exchange chromatography with pulsed amperometric detection
(HPAEC-PAD) in a carbohydrate analyzer system from Dionex
(Surrey, United Kingdom) as described previously (Plaine et al.,
2008). The total concentration of each cell wall component was
expressed as µg per mg of dried cell wall which was determined
by calibration from the standard curves of glucosamine, glucose,
and mannose monomers, and converted to a percentage of the
total cell wall.
Proteomic Analysis
Analysis of cell wall proteins was as described previously (Dutton
et al., 2014). Candida species were grown with or without CSF
as described for the HPLC analysis above. Briefly, 2mg of freeze
dried cell wall was mixed with 0.5M ammonium bicarbonate
in water containing 3mM dithiothreitol and heated at 60◦C
for 20min. Iodoacetamide (30 µl of 55mM stock solution) was
then added, and the suspension was incubated in the dark,
at 25◦C for 10min. Following addition of 30 µl of 20 mg/ml
trypsin, the suspension was incubated at 37◦C for 14 h and
centrifuged at 14,000 × g for 10min. The supernatant was
freeze-dried and extracted with 10% formic acid, and peptides
were purified using ZipTip mC18 pipette tips (Millipore) and
dissolved in 0.1% formic acid.
Samples (3 µl) were injected into an LC-MS system which
comprised an UltiMate 3000 LC instrument (Dionex Ltd.,
United Kingdom) fitted with a PepSwift monolithic poly(styrene-
codivinylbenzene) (PS-DVB) column (200µm inside diameter
[i.d.] by 5 cm; Dionex) coupled to an HCTultra ion trap
mass spectrometer (Bruker Daltonik GmbH, Bremen, Germany)
fitted with a low-flow nebulizer in the electrospray ionization
(ESI) source and controlled by HyStar software (version 4.0;
Bruker Daltonik). Peptides were separated at a flow rate of
2 µl/min using a linear gradient of 0–40% acetonitrile-water-
formic acid (80:20:0.04) (solvent B) in water-acetonitrile-formic
acid (97:3:0.05) (solvent A) over 40min, followed by a 1min
column wash in 90% solvent B and a 12-min equilibration
step in solvent A. MS/MS data (scan range, m/z 100–2,200;
averages 2) were acquired in positive data-dependent AutoMS(n)
mode using the esquireControl software program (version 6.2;
Bruker Daltonik). Up to three precursor ions were selected
from the MS scan (range, m/z 300–1,500; averages 3) in each
AutoMS(n) cycle. Precursors were actively excluded after being
selected twice within a 1-min window, and singly charged ions
were also excluded. Peptide peaks were detected (maximum
of 9,999 compounds above an intensity threshold of 50,000)
and deconvoluted automatically using Data Analysis software
(version 3.4; Bruker Daltonik). Mass lists in the form of
Mascot Generic Format (∗. mgf) files were created automatically
and used as inputs to Mascot MS/MS ion searches via a
local Mascot server (version 2.2; Matrix Science, London,
United Kingdom) with a database built from sequence files
available from Candida Genome Database (32). The Search
parameters used were the following: enzyme = trypsin; fixed
modifications = carbamidomethyl (C); variable modifications
= oxidation (M); mass values = monoisotopic; peptide mass
tolerance = 1.5 Da; fragment mass tolerance = 0.5 Da; max
missed cleavages = 1; instrument type = ESI-TRAP. Search
results were displayed by Mascot after selection of the following
parameters: standard scoring; require bold red; ion score or
expect cutoff= 0.05.
Statistical Analyses
Results from independent replicate experiments are expressed
as means ± SD. One-way ANOVA with a Dunnett’s post-
hoc test was used for statistical analysis. Significance was
determined as p< 0.05.
RESULTS
IC50 of Candida spp to Caspofungin
The susceptibility of each of the sequenced Candida spp.
strains, used in this study, to CSF was determined following
the CLSI-M27-A3 guidelines. C. albicans, C. dublinensis,
C. glabrata, and C. tropicalis were the most susceptible
to CSF (Table 1). The IC50 range for these susceptible
species was between 0.032 and 0.064µg/ml CSF (Table 1).
C. lusitaniae and C. parapsilosis had CSF IC50 measurements
of 0.5 and 1µg/ml, respectively, which was classified as
intermediate susceptibility and C. guilliermondii was resistant
to CSF (Table 1). Therefore, the order of susceptibility to
CSF from most susceptible to most resistant of the isolates
of the Candida spp. tested here was: C. albicans > C.
dubliniensis > C. glabrata > C. tropicalis > C. lusitaniae >
C. parapsilosis> C. guilliermondii.
Candida Species Have Differences in the
Ultrastructure of Their Cell Wall
Ultrastructural differences in the cell wall of eachCandida species
were investigated using high pressure freezing transmission
electron microscopy (TEM) which conserves the fungal cell wall
architecture. TEM analysis revealed that the inner core of the cell
wall of C. glabrata (Figure 1A, v) and C. tropicalis (Figure 1A, ii)
isolates was significantly thicker than the inner core of C. albicans
isolate (Figure 1A, i; Figure 1B). In contrast to this the inner core
of the C. guilliermondii cell wall (Figure 1A, vii) was significantly
thinner, in comparison to C. albicans (Figure 1A, i; Figure 1B).
Overall, the largest difference in the cell wall between theCandida
species was in the outer fibrillar layer (Figure 1B). The variations
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FIGURE 1 | The ultrastructure of the cell wall varies between Candida species. (A) TEMs of the cell wall of different Candida species: C. albicans (i), C. tropicalis (ii), C.
dublinensis (iii), C. lusitaniae (iv), C. glabrata (v), C. parapsilosis (vi) and C. guilliermondii (vii). Scale bars are 100 nm. (B) The thickness of the inner cell wall (glucan and
chitin) and outer fibrillar layer was determined from TEM pictures. Measurements from 30 cells that were sectioned so that cell wall thickness was even all around the
cell periphery. Significant differences (*p < 0.05) compared to C. albicans. Error bars are SD (n = 30).
in length of the outer fibrillar layer were classified as either
long (>65 nm), intermediate (30–65 nm), or short (<30 nm)
(Figure 1B). C. albicans and C. tropicalis had the longest outer
fibrillar layers, followed byC. dubliniensis andC. lusitaniaewhich
were classified as having intermediate fibril length (Figure 1B).C.
glabrata, C. parapsilosis, and C. guilliermondii isolates had short
outer fibrils on the cell surface, in comparison to the C. albicans
isolate (Figure 1B).
Candida Species Have Species Specific
GPI-Anchored Proteins Present on Their
Cell Surface
To determine the differences in the cell wall proteome between
the different Candida species, LC-MS/MS was used to identify
which covalently attached, predicted GPI-modified proteins
were present on the surface of each Candida species when
they were cultured in RPMI-1640 medium (Table 2). Here we
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TABLE 2 | Candida species-specific detection of cell wall GPI-anchored proteins by LC/MS/MS proteomics.
Species specific detection of putative GPI-anchored proteinsa,b,c
C. albicans C. dubliniensis C. lusitaniae C. parapsilosis C. tropicalis C. glabrata C. guilliermondii
Hyr1 (C1_13450W_A) Als4 (CD36_64610) Pga31
(CLUG_00164)
Pga24/Ywp1
(CPAR2_806670)
Pga24/Ywp1
(CTRG_01856)
Epa6
(CAGL0C00110g)
Pga24/Ywp1
(DEHA2A14366g)
Als2 (CD36_64800) Rbt1 (CLUG_03306) Pga30
(CPAR2_402000)
Epa3 (CAGL0E06688g)
Sap9 (CD36_83850) Awp4
(CAGL0J12001g)
aProteins assigned common names according to their C. albicans orthologs (Butler et al., 2009). Unique protein IDs in brackets.
bDetected in at least one of three biological replicate samples.
c In addition the following proteins were detected in all samples: Ssr1 (C7_00860W_A), Pga4 (C5_05390C_A), Crh11 (C4_02900C_A).
TABLE 3 | Caspofungin treatment specific proteins in different Candida species in RPMI-1640 medium.
Species Cell wall proteins specific to CSF-treated cellsa,b,c
C. albicans Utr2 (C3_01730C_A) Pga31 (C4_04080C_A) Ecm33 (C1_03190C_A) Rbt1 (C4_03520C_A) Pga29 (C4_04050C_A)
C. dubliniensis Utr2 (CD36_81610) Pga31 (CD36_43780) Phr2 (CD36_00220)
C. lusitaniae Utr2 (CLUG_02005) Pga62 (CLUG_00242) Als1 Phr1 (CLUG_01043) Pga24 (CLUG_00242)
C. parapsilosis Utr2 (CPAR2_503190) Als1
C. tropicalis Utr2 (CTRG_02140) Pga31 (CTRG_00350) Ecm33 (CTRG_00105)
C. glabrata Pir3 (CAGL0M08492g) Crh1 (CAGL0G09449g)
C. guilliermondii Utr2 (PGUG_00573) Pga30 (PGUG_01942) Plb5 (PGUG_01288)
aProteins assigned common names according to their C. albicans orthologs (Butler et al., 2009). Unique protein IDs in brackets.
bDetected in at least one of three biological replicate samples.
cThese proteins were not detected in the cell walls of untreated cultures.
have annotated the proteins according to their C. albicans
orthologs based on sequence similarity according to Candida
Genome Database (Skrzypek et al., 2016). A core set of predicted
cell wall proteins were identified in all species (Table 2). The
hyphal specific protein, Hyr1, was uniquely detected in the
cell wall of C. albicans, commensurate with it being a C.
albicans-specific hyphal-associated protein and C. albicans will
undergo filamentation in RPMI-1640 medium. GPI-anchored
proteins that were identified specifically in the cell wall of C.
dubliniensis included two Als proteins involved in adhesion
and the secreted aspartyl protease, Sap9 (Table 2). A fungal-
specific phospholipase and Pga59 orthologs were detected only
on the cell surface of C. lusitaniae (Table 2). The cell wall
of C. parapsilosis was found to contain orthologs of the yeast
wall protein, Ywp1/Pga24, and Pga30, a protein of unknown
function (Table 2).
Caspofungin treatment has been previously shown to alter cell
wall architecture and increases chitin production in C. albicans,
C. tropicalis, C. krusei, C. parapsilosis, and C. guilliermondii (9).
The effect of CSF treatment on the cell wall proteome of each
Candida species was also investigated by treating each Candida
spp. with their IC50 concentration of caspofungin (Table 3).
Certain proteins were detected only at the cell surface in response
to CSF treatment in addition to the proteins listed that are
found on the surface of untreated cells. The proteins expressed
in response to caspofungin varied between the different Candida
spp. Orthologs of the transglycosidase, Utr2, were detected on the
cell surface of the majority of Candida species in response to CSF
treatment with the exception of C. glabrata (Table 3). Orthologs
of Pga31, a GPI-anchored protein of unknown function was
detected on the surface of the species that were most sensitive
to CSF, such as C. albicans, C. dublinensis, and C. tropicalis in
response to CSF treatment (Table 3). A protein related to Pga30,
a member of the same family as Pga31 was detected in the cell
wall of C. guilliermondii treated with CSF. C. lusitaniae and C.
parapsilosis, which have intermediate susceptibility to CSF, were
found to have Als-like proteins on their cell surface in response
to CSF treatment (Table 3).
Cell Wall Composition of Different Candida
Species in the Presence or Absence of CSF
The carbohydrate composition of the cell walls of the different
Candida spp., in the presence or absence of an IC50 concentration
of caspofungin, was determined by acid hydrolysis of isolated cell
walls and analysis by high-performance liquid chromatography.
C. tropicalis had substantially higher chitin content than
C. albicans, whereas C. glabrata and C. guilliermondii had
significantly less chitin compared to C. albicans (Table 4). The
majority of Candida spp. had comparable levels of glucan in
the cell wall, with the exception of C. tropicalis, which had
significantly reduced glucan compared to C. albicans and C.
glabrata, which had a higher glucan content (Table 4). The
quantity of mannan in the cell wall was significantly reduced
in C. glabrata, C. parapsilosis, and C. guilliermondii compared
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 6 May 2020 | Volume 10 | Article 164
Walker and Munro Cell Wall Structure of Candida Species
TABLE 4 | Quantification of the components of the cell wall of Candida species,
with and without caspofungin treatment a,b,c*#.
Candida spp. % Dried cell wall
Chitin Glucan Mannan
C. albicans 4 ± 0.2
(100%)
66 ± 3
(100%)
30 ± 2
(100%)
C. albicans + CSFc 8 ± 1#
(200%)
43 ± 5#
(65%)
49 ± 3#
(163%)
C. tropicalis 5 ± 0.5*
(100%)
54 ± 2*
(100%)
41 ± 6
(100%)
C. tropicalis + CSF 12 ± 4
(240%)#
40 ± 7
(74%)#
49 ± 2
(120%)
C. dubliniensis 5 ± 0.8
(100%)
63 ± 4
(100%)
32 ± 1
(100%)
C. dubliniensis + CSF 13 ± 2#
(260%)
49 ± 6#
(78%)
38 ± 3
(119%)
C. lusitaniae 4 ± 0.1
(100%)
70 ± 8
(100%)
26 ± 2
(100%)
C. lusitaniae + CSF 9 ± 3#
(225%)
53 ± 11#
(76%)
38 ± 3#
(146%)
C. glabrata 2 ± 0.1*
(100%)
81 ± 5*
(100%)
17 ± 4*
(100%)
C. glabrata + CSF 1 ± 0.2
(50%)
67 ± 3#
(83%)
32 ± 2#
(188%)
C. parapsilosis 7 ± 5
(100%)
75 ± 4
(100%)
18 ± 3*
(100%)
C. parapsilosis +CSF 8 ± 3
(114%)
62 ± 2#
(83%)
30 ± 6#
(167%)
C. guilliermondii 2 ± 1*
(100%)
79 ± 6
(100%)
19 ± 2*
(100%)
C. guilliermondii + CSF 6 ± 0.5#
(300%)
59 ± 8#
(75%)
36 ± 5#
(189%)
aCell walls were acid hydrolyzed and released monosaccharide was detected.
bResults are expressed as a% of dried cell wall of the untreated data±SD. n= 3 biological
replicates. For + CSF samples % in brackets is relative to untreated samples which were
set as 100%.
c IC50 concentration of CSF was used for each species.
*Significantly different compared to untreated cells of C. albicans (P = 0.05).
#Significantly different compared to untreated cells of the same species (P = 0.05).
to C. albicans (Table 4) in agreement with the TEM analysis
which suggested these species have shorter mannan fibrils on
their outer surfaces. In most cases treatment with CSF resulted
in an increase in chitin content, with the exception of C.
glabrata and C. parapsilosis (Table 4). As expected all Candida
spp. isolates tested had a reduction in β-1,3-glucan in response
to CSF treatment. Exposure to an IC50 concentration of CSF
led to a significant increase in mannan content in all Candida
spp., with the exception of C. tropicalis and C. dublinensis
isolates (Table 4).
Candida Species Have Differences in
Surface Exposure of Chitin and Glucan in
Response to CSF Treatment
Exposure of chitin and glucan on the cell surface is known
to influence the immune recognition of fungal cells (Wheeler
and Fink, 2006; Wheeler et al., 2008; Mora-Montes et al.,
2011). Fluorescent staining was used to determine whether the
differences in outer fibril length between the Candida species
isolates correlated with variations in exposure of chitin and
β-1,3-glucan on the cell surface. The exposure of chitin was
determined using 25µg/ml Wheat Germ Agglutinin-Texas Red
(WGA-TR) and exposed β-1,3-glucan was stained with 5µg/ml
Fc:Dectin1- Alexa 488 (Table 5, Supplementary Figure 1). The
exposure of chitin and β-1,3-glucan, after treatment with an IC50
concentration of CSF for 6 h, was determined for each Candida
species isolate. Exposure of β-1,3-glucan was significantly higher
on the surface of untreated C. glabrata and C. guilliermondii
compared to C. albicans (Table 5). Treatment with CSF, at the
IC50, resulted in increased exposure of β-1,3-glucan on the
surface of C. albicans, C. tropicalis, C. dubliniensis, C. lusitaniae,
and C. guilliermondii (Table 5). However, CSF treatment had
no effect on the exposure of β-1,3-glucan of C. glabrata and
C. parapsilosis (Table 5). Measurement of exposed chitin on
the cell surface determined that the C. glabrata isolate had
less chitin exposed on the outer surface compared to C.
albicans isolate (Table 5). Treatment of C. albicans, C. tropicalis,
C. dubliniensis, C. lusitaniae, and C. guilliermondii with CSF
resulted in increased detection of chitin on the cell surface
(Table 5). The exception to this wasC. glabrata andC. parapsilosis
which had no change in exposure of chitin, in response to CSF
treatment (Table 5).
Relationship Between Phagocytosis and
Exposure of Chitin and Glucan
To determine the effect of exposure of chitin and glucan
on phagocytosis, the uptake of isolates of each Candida
species by J774 macrophages was determined. The yeasts
were cultured with and without sub-MIC CSF treatment and
phagocytosis correlated to the exposure of chitin and β-1,3-
glucan on the cell surface (Figure 2, Supplementary Table 1).
The majority of Candida species had low levels of chitin and
β-1,3-glucan exposed naturally on the cell surface, under the
growth conditions used (Figure 2A). The exception was C.
glabrata and C. guilliermondii which had significantly more
β-1,3-glucan exposed on the cell surface, compared to C.
albicans, which correlated with these Candida species having
the highest phagocytosis by J774 macrophages (Figure 2A).
To determine the effect of altered exposure of β-1,3-glucan
and chitin, the phagocytosis of CSF-treated cells was also
measured (Figure 2B). In all cases the combined increase
in exposure of chitin and β-1,3-glucan, in CSF-treated cells,
resulted in a significant decrease in phagocytosis by macrophages
(Figure 2B). Treatment of C. glabrata and C. parapsilosis
with CSF had little effect on the exposure of the outer cell
wall components and consequently there was no significant
change in their phagocytosis by macrophages (Figure 2B).
Pearson Correlation analysis demonstrated that there was
a positive correlation between glucan exposure and chitin
exposure and caspofungin treatment [r(12) = 0.703, p =
0.005; r(12) = 0.699, p = 0.005 respectively] but a negative
correlation between % phagocytosis and caspofungin treatment
[r(12) =−0.763, p= 0.002].
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TABLE 5 | Quantification of the exposure of β-1,3-glucan and chitin of Candida species, with and without caspofungin treatmenta.
Candida species Glucan exposure (mean fluorescence intensity) Chitin exposure (mean fluorescence intensity)
No treatment Caspofungin treatment No treatment Caspofungin treatment
C. albicans 179 ± 20 450 ± 34# 167 ± 17 488 ± 51#
C. dubliniensis 211 ± 14 374 ± 52# 160 ± 26 404 ± 40#
C. glabrata 273 ± 21* 257 ± 39 89 ± 18* 79 ± 20
C. tropicalis 185 ± 41 607 ± 66# 178 ± 22 516 ± 54#
C. lusitaniae 171 ± 29 468 ± 49# 159 ± 31 438 ± 35#
C. parapsilosis 201 ± 13 189 ± 30 172 ± 28 202 ± 45
C. guilliermondii 263 ± 36* 537 ± 72# 160 ± 29 445 ± 49#
aThe average relative β-1,3-glucan and chitin contents of individual cells from different Candida species were determined by measuring the intensity of Fc:Dectin1–Alexa488 and WGA-
Texas Red fluorescence. Measurements were made on untreated control cultures and after growth with caspofungin at the specific IC50 for each species (as determined in Table 1).
Statistical differences are shown for comparison to untreated cells of C. albicans (*P = 0.05) or untreated cells of the same species (#P = 0.05), and data are means with standard
deviations (n = 50).
Cytokine Production Varies Between
Candida Species and Is Reduced in
Response to CSF Treatment
Increased exposure of β-1,3-glucan has previously been shown
to stimulate cytokine production whereas increased exposure
of chitin has been shown to result in a decrease in cytokine
production (Wheeler and Fink, 2006; Wheeler et al., 2008; Mora-
Montes et al., 2011). To determine the cytokine production
stimulated by the different Candida species, TNFα production
was measured when untreated live cells of each Candida species
were exposed to J774 macrophages for 4 h (Figure 3). Live cells
of C. albicans and C. dubliniensis stimulated the highest levels
of TNFα production (Figure 3). The other Candida species all
stimulated very low levels of TNFα (Figure 3), which remained
unchanged even after 24 h (data not shown). Treatment with an
IC50 concentration of CSF, specific to eachCandida species, led to
a significant decrease in TNFα production in C. albicans and C.
dubliniensis, compared to untreated cells (Figure 3). Treatment
with CSF had no effect on TNFα production in the otherCandida
species isolates, with the exception of the C. tropicalis isolate
which had a significant increase in TNFα production compared
to untreated cells (Figure 3). C. tropicalis also had the highest
level of surface-exposed β(1,3)-glucan when treated with CSF.
DISCUSSION
This study aimed to directly compare the structure and
composition of the cell walls of different Candida species,
examine how the cell wall was altered in response to caspofungin
treatment and assess how this impacted on fungal: murine
macrophage interactions. We demonstrated that the length of
the outer fibrillar layer varied between the species isolates tested
and that, in most cases, reduced fibril length correlated with
increased exposure of β-1,3-glucan on the cell surface. C. glabrata
and C. guilliermondii, which had naturally more β-1,3-glucan
exposed on the cell surface, were phagocytosed more efficiently
by J774 macrophages. This is in agreement with a previous study
that showed that in a mixed population of C. albicans and C.
glabrata cells, C. glabrata is preferentially phagocytosed over C.
albicans (Keppler-Ross et al., 2010). Similar to our observations,
Estrada-Mata et al. (2016) also demonstrated that C. parapsilosis
had less mannan content but more β-1,3-glucan exposed on
the surface compared to C. albicans which correlated with an
increase in cytokine production by human PBMCs (Estrada-
Mata et al., 2016). Dectin-1 has been shown to play an important
role in recognition of C. parapsilosis by human PBMCs (Toth
et al., 2013). In our study C. parapsilosis induced little cytokine
production from J774 macrophages at 4 h, but differences in the
source of immune cells and the time that Candida cells were
exposed to immune cells before performing the ELISAs may
account for these differences.
There were also notable differences in the cell wall proteins
that reside on the surface of the different Candida species, for
example, the GPI-anchored proteins, Epa3, Epa6, and Awp4,
were identified specifically on the cell wall of C. glabrata
under the growth conditions tested. These are known to be
adhesion proteins inC. glabratawhich are associated with biofilm
formation (de Groot et al., 2008; Kraneveld et al., 2011). The
presence of cell wall proteins on the cell surface of C. glabrata,
C. parapsilosis, and C. tropicalis has been shown to be dependent
on the growth conditions tested (Karkowska-Kuleta et al., 2019).
Treatment with CSF is known to result in a compensatory
increase in cell wall chitin levels and result in increased exposure
of chitin and β-1,3-glucan on the surface of C. albicans cells
(Wheeler and Fink, 2006; Walker et al., 2008, 2013; Wheeler
et al., 2008; Mora-Montes et al., 2011). All of the Candida
species isolates tested, with the exception of C. glabrata and C.
parapsilosis isolates, demonstrated a compensatory increase in
cell wall chitin content in response to CSF treatment. Likewise,
treatment with CSF also resulted in an increase in exposure
of chitin and β-1,3-glucan on the cell surface for the majority
of species tested. Notable exceptions were C. glabrata and C.
parapsilosis with no changes in glucan exposure in response
to caspofungin treatment. This increase in exposure of the
inner cell wall polysaccharides, did not increase the number
of macrophages that had engulfed the fungal cells in fact
caspofungin treatment resulted in a reduction in % phagocytosis.
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FIGURE 2 | Correlation between exposure of chitin and glucan on the cell surface of Candida species and phagocytosis by J774 macrophages. The values for
exposure of chitin and β-1,3-glucan were taken from Table 5. Phagocytosis of Candida spp. by macrophages was determined by fluorescence microscopy. All cells
were stained with 10µg/ml FITC prior to exposure to macrophages. FITC-stained cells were exposed to J774 macrophages for 1 h, after which non-phagocytosed
cells were stained with 25µg/ml CFW. The number of macrophages which had phagocytosed Candida cells were then counted (n = 300). (A) Untreated Candida
spp. cells. (B) CSF treated Candida cells. Black shapes = chitin (WGA-TR), gray shapes = glucan (Fc:dectin1-alexa488).
The majority of live Candida spp. cells stimulated low levels
of TNFα production. In comparison the C. albicans and C.
dublinensis isolates stimulated elevated levels of TNFα but
these levels were significantly reduced when macrophages were
exposed to the same isolates after caspofungin treatment. A
notable exception to this trend was CSF-treated C. tropicalis
isolate which stimulated significantly elevated TNFα production
compared to untreated cells attaining a level comparable to C.
albicans and C. dublinensis. C. tropicalis had the highest level
of Fc-dectin1-Alex488 staining with and without caspofungin
treatment. These findings suggested that the immune stimulatory
properties of the differentCandida species is not solely dependent
upon β-1,3-glucan exposure and recognition by Dectin-1 and
other factors may come into play (Wagener et al., 2014). Recently,
treatment with either fragments of chitin or β-1,3-glucan from
Aspergillus fumigatus were shown to stimulate production of
TNFα. In addition, combined treatment with both chitin and β-
1,3-glucan resulted in a synergistic increase in TNFα production
(Dubey et al., 2014). This is in contrast with the findings here
where other changes at the cell surface including increased
chitin exposure appeared to override any stimulation of the
immune response elicited by glucan exposure. The differences
in stimulation of the immune response may be due to variations
in size of the cell wall polysaccharides and the way the polymer
is presented to immune cells. Small particles of chitin are
known to illicit a greater cytokine response compared to larger
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FIGURE 3 | Candida species stimulate different immune responses. Live cells of each Candida species, which had been grown with or without an IC50 concentration
of caspofungin for 6 h, were exposed to J774 macrophages for 4 h. After 4 h of co-incubation, supernatants were collected and cytokine production was measured.
Significant differences (#p < 0.05) compared to C. albicans. Significant differences (*p < 0.05) compared to untreated cells of the same species. Error bars are SD
(n = 3).
chitin fragments (Da Silva et al., 2009). Likewise, differences in
polysaccharide structure may influence the immune response.
The chitin microfibrils of A. fumigatus and C. albicans may
have a different architecture, which could influence the immune
response (Gow and Gooday, 1983; Lenardon et al., 2007).
Recently, hyphal β-1,3-glucan of C. albicans was found to have
a unique cyclical structure that is absent in β-1,3-glucan from
the yeast form (Lowman et al., 2014). Compared to β-1,3-
glucan from yeast cells, hyphal glucan was shown to induce an
immune response in macrophages and human peripheral blood
mononuclear cells through a Dectin-1-dependent mechanism.
In addition CSF treatment has also been shown to not only
effect β-1,3-glucan exposure but also its nano-structure with the
density of dectin-1 binding sites increasing leading to increased
phagocytosis by dendritic cells (Lin et al., 2016). To dissect
further whether glucan and/or chitin plays the main role in
caspofungin-mediated dampening of the immune response, it
would be interesting to evaluate the effect of blocking receptors of
both polysaccharides on interaction with macrophages. Another
consideration is that the change in GPI-modified proteins
on the cell surface, in response to CSF treatment, may also
influence the interaction with immune cells. For example, the
transglycosidase, Utr2, was detected on the surface of the
majority of Candida species in response to CSF treatment. Utr2
is involved in crosslinking chitin and β-1,3-glucan and forms
part of a compensatory mechanism activated in response to cell
weakening induced by echinocandin treatment (Pardini et al.,
2006). A C. albicans utr21 mutant was found to have the same
susceptibility to micafungin as the wild type (Alberti-Segui et al.,
2004). Deletion of UTR2 in C. albicans resulted in attenuated
virulence in a mouse model of systemic candidiasis. Despite this
attenuation in virulence the fungal burdens from the kidneys of
mice infected with the utr21 mutant were comparable to that
of mice infected with wild-type C. albicans. This suggests that in
the absence of UTR2, cells do not elicit the same inflammatory
response as wild-type cells and enables the utr21 mutant to be
tolerated by the host, leading to survival of the infected mice
(Pardini et al., 2006). Therefore, the increased abundance of Utr2
on the cell surface in response to caspofungin treatment may also
contribute to altered interactions with host cells.
Candida guilliermondii and C. parapsilosis are known to be
intrinsically less sensitive to the echinocandins. Both species
had thin walls and their cell wall proteomes differed from CSF-
susceptible species. Pga24/Ywp1 orthologs were detected on their
cell surfaces when grown on RPMI-1640 medium. In C. albicans
Pga24 is associated with the yeast cell wall (Granger et al., 2005)
and here was not detected when C. albicanswas grown on RPMI-
1640 medium. Mutation of PGA24 did not alter echinocandin
susceptibility of C. albicans (Plaine et al., 2008). The role of this
surface protein in echinocandin susceptibility ofC. guilliermondii
and C. parapsilosis remains to be determined.
The ability of live cells of each isolate of the different Candida
species to stimulate cytokine production varied significantly
(Figure 3). C. albicans and C. dubliniensis isolates, tested here,
elicited the highest production of TNFα. In contrast to this
the other isolates representing the different Candida species
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stimulated negligible levels of TNFα when exposed to J774
macrophages for 4 h. Previous work has demonstrated that C.
parapsilosis, C. tropicalis, C. lusitaniae, and C. guilliermondii in
addition to C. albicans and C. dubliniensis, stimulated production
of TNFα from murine peritoneal macrophages and human
PBMCs after 24 h (Aybay and Imir, 1996; Navarro-Arias et al.,
2019). The most likely reason for the difference observed at
the 4 h time point is that C. albicans and C. dubliniensis are
the only two species which form true hyphae and were capable
of germinating within macrophages, and consequently escaping
from macrophages, faster than any of the other Candida species.
For example, C. glabrata yeast cells have been shown to replicate
within macrophages for up to 3 days before causing lysis of
the macrophage (Seider et al., 2011). Therefore, the low levels
of cytokine production that have been observed as a result
of exposure of macrophages to live C. glabrata is thought to
be due to C. glabrata evading host defenses by hiding within
immune cells (Seider et al., 2011, 2014; Brunke et al., 2014).
However, it is possible for C. glabrata to filament under certain
conditions. Prolonged exposure of C. glabrata to macrophages
led to filamentous growth which was a result of a point mutation
in CHS2 (Lewis et al., 2013). Treatment of C. albicans and C.
dubliniensis with CSF resulted in a decrease in production of
TNFα and reduced phagocytosis by macrophages. Exposure of
C. albicans to caspofungin has previously been shown to reduce
cytokine production in both live and heat killed C. albicans cells,
as a result of increased exposure of chitin on the cell surface
(Mora-Montes et al., 2011).
Here we examined caspofungin induced changes at the
cell surface of representative isolates of different Candida
species. We detected drug-induced changes in the repertoire
of covalently attached surface proteins and alterations in
the exposure of cell wall carbohydrates of contributing to
their recognition by J774 macrophages. The cell surface is
highly variable both between and within species and so
these investigations should be expanded to a wider range of
isolates of the different species to determine the extent of cell
surface variability and how it impacts on host interactions and
drug susceptibility.
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